A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

Recruiting

Phase 3

LP352A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

Sponsor:

Longboard Pharmaceuticals

Code:

NCT06908226

Conditions

Developmental and Epileptic Encephalopathy

Eligibility Criteria

Sex: All

Age: 2 - 66

Healthy Volunteers: Not accepted

Interventions

LP352

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Longboard Pharmaceuticals on 2025-04-11.